Found 6 results
Author Title Type [ Year(Asc)]
Filters: Keyword is Tumor Cells  [Clear All Filters]
2006
M. Shortencar Tartis, McCallan, J., Lum, A. F. H., LaBell, R., Stieger-Vanegas, S. M., Matsunaga, T. O., and Ferrara, K. W., “Therapeutic effects of paclitaxel-containing ultrasound contrast agents.”, Ultrasound in medicine & biology, vol. 32, no. 11, pp. 1771-80, 2006.
B. P. Dolan, Gibbs, K. D., and Ostrand-Rosenberg, S., “Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.”, Journal of immunology (Baltimore, Md. : 1950), vol. 176, no. 3, pp. 1447-55, 2006.
2000
W. T. Tino, Huber, M. J., Lake, T. P., Greene, T. G., Murphy, G. P., and Holmes, E. H., “Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA).”, Hybridoma, vol. 19, no. 3, pp. 249-57, 2000.
1997
L. E. Bermudez, Petrofsky, M., and Goodman, J., “Exposure to low oxygen tension and increased osmolarity enhance the ability of Mycobacterium avium to enter intestinal epithelial (HT-29) cells.”, Infection and immunity, vol. 65, no. 9, pp. 3768-73, 1997.
1994
L. E. Bermudez and Young, L. S., “Factors affecting invasion of HT-29 and HEp-2 epithelial cells by organisms of the Mycobacterium avium complex.”, Infection and immunity, vol. 62, no. 5, pp. 2021-6, 1994.
L. E. Bermudez, Young, L. S., and Inderlied, C. B., “Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells.”, Antimicrobial agents and chemotherapy, vol. 38, no. 5, pp. 1200-2, 1994.